Pharsight

Drugs that contain Lidocaine

1. Ztlido patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10765640 SCILEX PHARMS INC Non-aqueous patch
May, 2031

(7 years from now)

US11278623 SCILEX PHARMS INC Non-aqueous patch
May, 2031

(7 years from now)

US9931403 SCILEX PHARMS INC Non-aqueous patch
May, 2031

(7 years from now)

US10765749 SCILEX PHARMS INC Non-aqueous patch
May, 2031

(7 years from now)

US9925264 SCILEX PHARMS INC Non-aqueous patch
May, 2031

(7 years from now)

US9283174 SCILEX PHARMS INC Non-aqueous patch
May, 2031

(7 years from now)

Market Authorisation Date: 28 February, 2018

Treatment: Method for relieving the pain associated with post-herpetic neuralgia

Dosage: PATCH;TOPICAL

How can I launch a generic of ZTLIDO before it's drug patent expiration?
More Information on Dosage

ZTLIDO family patents

Family Patents

2. Ztlido patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11786455 SCILEX PHARMS Non-aqueous patch
May, 2031

(7 years from now)

US11793766 SCILEX PHARMS Non-aqueous patch for the relief of pain
May, 2031

(7 years from now)

Market Authorisation Date: 28 February, 2018

Treatment: Method for relieving the pain associated with post-herpetic neuralgia

Dosage: PATCH;TOPICAL

How can I launch a generic of ZTLIDO before it's drug patent expiration?
More Information on Dosage

ZTLIDO family patents

Family Patents